Soleus Capital Management’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$29.9M	Buy	+2,185,000	New	+$29.9M	1.98%	14
2024 Q2	–	Sell	-10,000	Closed	-$150K	–	112
2024 Q1	$150K	Buy	+10,000	New	+$150K	0.01%	88
2023 Q4	–	Sell	-372,000	Closed	-$5.21M	–	102
2023 Q3	$5.21M	Buy	+372,000	New	+$5.21M	0.48%	52